Vitamin D2-Enriched Button Mushroom (Agaricus bisporus) Improves Memory in Both Wild Type and APPswe/PS1dE9 Transgenic Mice

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Bennett, Louise ^a   Kersaitis, Cindy ^b   Macaulay, Stuart Lance ^a   Münch, Gerald ^b   Niedermayer, Garry ^b   Nigro, Julie ^a   Payne, Matthew ^a   Sheean, Paul ^a   Vallotton, Pascal ^a   Zabaras, Dimitrios ^a   Bird, Michael ^b  

^a CSIRO   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CALCIUM; CHOLESTEROL; ERGOCALCIFEROL; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LANOSTEROL; NERVE GROWTH FACTOR; PROTEIN; AUTACOID; CYTOKINE; VITAMIN D;

AGARICUS BISPORUS; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN DEVELOPMENT; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN REGULATION; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEARNING; LIVER TOXICITY; MALE; MEMORY; METABOLITE; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; TISSUE LEVEL; TRANSGENIC MOUSE; VITAMIN BLOOD LEVEL; AGARICUS; ANIMAL; ANIMAL FOOD; BLOOD; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; LIVER; MAZE TEST; METABOLISM; PATHOLOGY; TIME;

AGARICUS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMAL FEED; ANIMALS; BRAIN; CALCIUM; CHOLESTEROL; CYTOKINES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; ERGOCALCIFEROLS; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; MALE; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; TIME FACTORS; VITAMIN D;

EID: 84885713061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076362     Document Type: Article

References (104)

1. Wimo A, Prince M (2010) World Alzheimer Report: The global economic impact of dementia. Alzheimer's Disease International.
2. Gardener S, Gu YM, Rainey-Smith SR, Keogh JB, Clifton PM, et al. (2012) Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry 2.
3. Scheltens P, Twisk J, Blesa R, Scarpini E, Von Arnim C, et al. (2012) Souvenaid (R) Improves Memory in Drug-Naive Patients with Mild Alzheimer's Disease: Results from a Randomized, Controlled, Double-Blind Study (Souvenir II). Journal of Alzheimers Disease 29: 37-38.
4. Scheltens P, Twisk JWR, Blesa R, Scarpini E, von Arnim CAF, et al. (2012) Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial. Journal of Alzheimers Disease 31: 225-236.
5. Wang YJ, Thomas P, Zhong JH, Bi FF, Kosaraju S, et al. (2009) Consumption of Grape Seed Extract Prevents Amyloid-beta Deposition and Attenuates Inflammation in Brain of an Alzheimer's Disease Mouse. Neurotoxicity Research 15: 3-14.
6. Yang FS, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry 280: 5892-5901.
7. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ, (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal of Neurochemistry 102: 1095-1104.
8. Vingtdeux V, Giliberto L, Zhao HT, Chandakkar P, Wu QL, et al. (2010) AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-beta Peptide Metabolism. Journal of Biological Chemistry 285: 9100-9113.
9. Lim GP, Calon F, Morihara T, Yang FS, Teter B, et al. (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. Journal of Neuroscience 25: 3032-3040.
10. Annweiler C, Schott AM, Berrut G, Chauvire V, Le Gall D, et al. (2010) Vitamin D and Ageing: Neurological Issues. Neuropsychobiology 62: 139-150.
11. Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, et al. (2010) Dietary intake of vitamin D and cognition in older women A large population-based study. Neurology 75: 1810-1816.
12. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, et al. (2010) Association of vitamin D deficiency with cognitive impairment in older women Cross-sectional study. Neurology 74: 27-32.
13. Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM, (2008) Higher serum vitamin D-3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 25: 539-543.
14. Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Guervit H, et al. (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku Journal of Experimental Medicine 212: 275-282.
15. Sutherland MK, Somerville MJ, Yoong LKK, Bergeron C, Haussler MR, et al. (1992) Reduction of Vitamin D-hormone receptor messenger RNA levels in Alzheimer's as compared to Huntington hippocampus- correlation with calbindin-28K messenger RNA levels. Molecular Brain Research 13: 239-250.
16. Gezen-Ak D, Dursun E, Bilgic B, Hanagasi H, Ertan T, et al. (2012) Vitamin D Receptor Gene Haplotype Is Associated with Late-Onset Alzheimer's Disease. Tohoku Journal of Experimental Medicine 228: 189-196.
17. Dursun E, Gezen-Ak D, Yilmazer S, (2011) A Novel Perspective for Alzheimer's Disease: Vitamin D Receptor Suppression by Amyloid-beta and Preventing the Amyloid-beta Induced Alterations by Vitamin D in Cortical Neurons. Journal of Alzheimers Disease 23: 207-219.
18. Bini F, Martinesi M, Garcia-Gil M, Meacci B, (2009) Neuroprotective effect of Vitamin D on the 1-42 beta-amyloid peptide-induced cytotoxicity in differentiated SH-SY5Y cells. A role for sphingolipids. Naunyn-Schmiedebergs Archives of Pharmacology 380: 361-361.
19. Gezen-Ak D, Dursun E, Yilmazer S (2012) Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement. Neurological Science.
20. Eyles DW, Burne THJ, Mcgrath JJ Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. In press.
21. Holick MF, (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Molecular Aspects of Medicine 29: 361-368.
22. Wang SH, (2009) Epidemiology of vitamin D in health and disease. Nutrition Research Reviews 22: 188-203.
23. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, et al. (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews 9: 709-715.
24. Bischoff-Ferrari H, (2010) Health effects of vitamin D. Dermatologic Therapy. 23: 23-30.
25. Tukaj C, (2008) Adequate level of vitamin D is essential for maintaining good health. Postepy Higieny I Medycyny Doswiadczalnej 62: 502-510.
26. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, et al. (2008) Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice. Endocrine Reviews 29: 726-776.
27. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T, (2009) Improving Effects of the Mushroom Yamabushitake (Hericium erinaceus) on Mild Cognitive Impairment: A Double-blind Placebo-controlled Clinical Trial. Phytotherapy Research 23: 367-372.
28. Serra-Majem L, Bes-Rastrollo M, Roman-Vinas B, Pfrimer K, Sanchez-Villegas A, et al. (2009) Dietary patterns and nutritional adequacy in a Mediterranean country. British Journal of Nutrition 101: S21-S28.
29. Perez-Llamas F, Lopez-Contreras MJ, Blanco MJ, Lopez-Azorin F, Zamora S, et al. (2008) Seemingly paradoxical seasonal influences on vitamin D status in nursing-home elderly people from a Mediterranean area. Nutrition 24: 414-420.
30. Koyyalamudi SR, Jeong SC, Song CH, Cho KY, Pang G, (2009) Vitamin D2 Formation and Bioavailability from Agaricus bisporus Button Mushrooms Treated with Ultraviolet Irradiation. Journal of Agricultural and Food Chemistry 57: 3351-3355.
31. Jasinghe VJ, Perera CO, Barlow PJ, (2006) Vitamin D-2 from irradiated mushrooms significantly increases femur bone mineral density in rats. Journal of Toxicology and Environmental Health-Part a-Current Issues 69: 1979-1985.
32. Ozzard A, Hear G, Morrison G, Hoskin M, (2008) Vitamin D deficiency treated by consuming UVB-irradiated mushrooms. British Journal of General Practice 58: 644-645.
33. Lee GS, Byun HS, Yoon KH, Lee JS, Choi KC, et al. (2009) Dietary calcium and vitamin D-2 supplementation with enhanced Lentinula edodes improves osteoporosis-like symptoms and induces duodenal and renal active calcium transport gene expression in mice. European Journal of Nutrition 48: 75-83.
34. Yu J, Gattoni-Celli M, Zhu H, Bhat NR, Sambamurti K, et al. (2011) Vitamin D-3-Enriched Diet Correlates with a Decrease of Amyloid Plaques in the Brain of A beta PP Transgenic Mice. Journal of Alzheimers Disease 25: 295-307.
35. Mattila P, Salo-Vaananen P, Konko K, Aro H, Jalava T, (2002) Basic composition and amino acid contents of mushrooms cultivated in Finland. Journal of Agricultural and Food Chemistry 50: 6419-6422.
36. Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, et al. (2012) Comparison of vitamin D-2 and vitamin D-3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. American Journal of Clinical Nutrition 95: 1357-1364.
37. Glover M, Glover J, Morton RA, (1952) Provitamin-D3 in tissues and the conversion of cholesterol to 7-dehydrocholesterol in vivo. Biochemical Journal 51: 1-9.
38. Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, et al. (2004) A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. European Journal of Biochemistry 271: 4178-4188.
39. Bogh MKB, Schmedes AV, Philipsen PA, Thieden E, Wulf HC, (2010) Vitamin D Production after UVB Exposure Depends on Baseline Vitamin D and Total Cholesterol but Not on Skin Pigmentation. Journal of Investigative Dermatology 130: 546-553.
40. Daly R, Gagnon C, Lu Z, Magliano D, Dunstan D, et al. (2011) Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: A national, population-based study. Clin Endocrinol Dec 15.
41. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, et al. (2010) 25-Hydroxyvitamin D, Dementia and Cerebrovascular Pathology in Elders Receiving Home Services. Neurology 74: 18-26.
42. Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM, (2008) Higher Serum Vitamin D3 Levels Are Associated with Better Cognitive Test Performance in Patients with Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders 25: 539-543.
43. Llewellyn DJ, Lang IA, Langa KM, Melzer D, (2011) Vitamin D and Cognitive Impairment in the Elderly U.S. Population. Journals of Gerontology Series a-Biological Sciences and Medical Sciences 66: 59-65.
44. Slinin Y, Paudel M, Taylor BC, Ishani A, Rossom R, et al. (2012) Association Between Serum 25(OH) Vitamin D and the Risk of Cognitive Decline in Older Women. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.
45. Przybelski RJ, Binkley NC, (2007) Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Archives of Biochemistry and Biophysics 460: 202-205.
46. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, et al. (2010) Vitamin D and Risk of Cognitive Decline in Elderly Persons. Archives of Internal Medicine 170: 1135-1141.
47. Lee DM, Tajar A, Ulubaev A, Pendleton N, O'Neill TW, et al. (2009) Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. Journal of Neurology Neurosurgery and Psychiatry 80: 722-729.
48. Annweiler C, Fantino B, Le Gall D, Schott A-M, Berrut G, et al. (2011) Severe Vitamin D Deficiency is Associated with Advanced-Stage Dementia in Geriatric Inpatients. Journal of the American Geriatrics Society 59: 169-171.
49. Sato Y, Asoh T, Oizumi K, (1998) High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 23: 555-557.
50. Mizwicki M, T, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, et al. (2012) Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. Journal of Alzheimers Disease 29: 51-62.
51. Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, et al. (2011) 1a,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-b peptide(1-40) from mouse brain across the blood-brain barrier. Fluids and Barriers of the CNS 8.
52. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, et al. (2012) Higher Vitamin D Dietary Intake Is Associated With Lower Risk of Alzheimer's Disease: A 7-Year Follow-up. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.
53. Sutherland MK, Somerville MJ, Yoong LKK, Bergeron C, Haussler MR, et al. (1992) Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Molecular Brain Research 13: 239-250.
54. Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, et al. (2009) Genome-wide Association Study Implicates a Chromosome 12 Risk Locus for Late-Onset Alzheimer Disease. American Journal of Human Genetics 84: 35-43.
55. Wang L, Hara K, Van Baaren JM, Price JC, Beecham GW, et al. (2012) Vitamin D receptor and Alzheimer's disease: a genetic and functional study. Neurobiology of Aging.
56. Beelman R, Kalaras M (2009) Pulsed UV irradiated, tissue, substrate, spent substrate or component of filamentous fungi useful as nutritional food product, has increased levels of Vitamin D when compared with non-irradiated pulsed UV filamentous fungi. Penn State Res Found (Psrf). 28.
57. Stephensen CB, Zerofsky M, Burnett DJ, Lin PP, Hammock BD, et al. (2012) Ergocalciferol from mushrooms or supplements consumed witha standard meal icnreases 25-hydroxyergocalciferol but decreases 25-hydroxycholecalcifeol in the serum of healthy adults. Journal of Nutrition.
58. Kalaras MD, Beelman RB, Holick MF, Elias RJ, (2012) Generation of potentially bioactive ergosterol-derived products following pulsed ultraviolet light exposure of mushrooms (Agaricus bisporus). Food Chemistry 135: 396-401.
59. Dubost NJ, Ou B, Beelman RB, (2007) Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chemistry 105: 727-735.
60. Sheean P, Rout MK, Head RJ, Bennett LE, (2012) Modulation of in vitro activity of zymogenic and mature recombinant human ss-secretase by dietary plants. Febs Journal 279: 1291-1305.
61. Anonymous (2006) Nutrient reference values for Australia and New Zealand. Food Australia 58: 298-298.
62. Rapuri PB, Gallagher JC, Haynatzki G, (2004) Effect of vitamins D-2 and D-3 supplement use on serum 25OHD concentration in elderly women in summer and winter. Calcified Tissue International 74: 150-156.
63. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, et al. (2012) A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice, the CopD study. Journal of Clinical Endocrinology and Metabolism.
64. Ding Y, Qiao AM, Wang ZQ, Goodwin JS, Lee ES, et al. (2008) Retinoic Acid Attenuates beta-Amyloid Deposition and Rescues Memory Deficits in an Alzheimer's Disease Transgenic Mouse Model. Journal of Neuroscience 28: 11622-11634.
65. Lalonde R, Kim HD, Maxwell JA, Fukuchi K, (2005) Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/Delta E9 mice with amyloid plaques. Neuroscience Letters 390: 87-92.
66. Cao DF, Lu HL, Lewis TL, Li L, (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. Journal of Biological Chemistry 282: 36275-36282.
67. Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du DG, et al. (2009) Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice. Cell 139: 1157-1169.
68. Du J, Sun B, Chen K, Zhang L, Liu SB, et al. (2009) Metabolites of Cerebellar Neurons and Hippocampal Neurons Play Opposite Roles in Pathogenesis of Alzheimer's Disease. Plos One 4.
69. Reiserer RS, Harrison FE, Syverud DC, McDonald MP, (2007) Impaired spatial learning in the APP(Swe)+PSEN1 Delta E9 bigenic mouse model of Alzheimer's disease. Genes Brain and Behavior 6: 54-65.
70. Lalonde R, Kim HD, Fukuchi K, (2004) Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/Delta E9 mice. Neuroscience Letters 369: 156-161.
71. Stover KR, Brown RE, (2012) Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Behavioural Brain Research 231: 75-85.
72. Briones T, Darwish H (2012) Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden. Journal of Neuroinflammation 9.
73. Kesby JP, Eyles DW, Burne THJ, McGrath JJ, (2011) The effects of vitamin D on brain development and adult brain function. Molecular and Cellular Endocrinology 347: 121-127.
74. Kiraly SJ, Kiraly MA, Hawe RD, Makhani N, (2006) Vitamin D as a neuroactive substance: Review. Thescientificworldjournal 6: 125-139.
75. Eyles DW, Burne THJ, McGrath JJ (2012) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology.
76. Phan CW, Wong WL, David P, Naidu M, Sabaratnam V (2012) Pleurotus giganteus (Berk.) Karunarathna & K.D. Hyde: Nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells. Bmc Complementary and Alternative Medicine 12.
77. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, et al. (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiology of Disease 24: 516-524.
78. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, et al. (2001) Age-dependent changes in brain, CSF, and plasma amyloid beta protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 21: 372-381.
79. Xiong HQ, Callaghan D, Wodzinska J, Xu JJ, Premyslova M, et al. (2011) Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neuroscience Bulletin 27: 221-232.
80. Vehmas AK, Borchelt DR, Price DL, McCarthy D, Wills-Karp M, et al. (2001) beta-amyloid peptide vaccination results in marked changes in serum and brain A beta levels in APPswe/PS1 Delta E9 mice, as detected by SELDI-TOF-based ProteinChip (R) technology. DNA and Cell Biology 20: 713-721.
81. Oh ES, Troncoso JC, Tucker SMF, (2008) Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease. Neuromolecular Medicine 10: 195-207.
82. Cohen MP, Shearman CW, (2009) Reduction of A beta 42 in brains of transgenic APPswe mice by 2-3-chlorophenylaminophenylacetate. Clinical and Experimental Pharmacology and Physiology 36: 1099-1103.
83. Bennett LE, Sheean P, Zabaras D, Head RJ (accepted) Heat-stable components of Wood Ear mushroom (Auricularia polytricha) inhibit in vitro activity of beta secretase (BACE1). International Journal for Medicinal Mushrooms.
84. Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T, (1999) Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. Journal of Neurochemistry 72: 1466-1471.
85. Szelenyi J, (2001) Cytokines and the central nervous system. Brain Research Bulletin 54: 329-338.
86. Bogdan C, Vodovotz Y, Nathan C, (1991) Macrophage de-activation by interleukin-10. Journal of Experimental Medicine 174: 1549-1555.
87. Malefyt RD, Abrams J, Bennett B, Figdor CG, Devries JE, (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes- an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine 174: 1209-1220.
88. Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, et al. (2008) Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice. Journal of Neurochemistry 105: 584-594.
89. Garcion E, Sindji L, Montero-Menei C, Andre C, Brachet P, et al. (1998) Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D-3. Glia 22: 282-294.
90. Kalueff AV, Tuohimaa P, (2007) Neurosteroid hormone vitamin D and its utility in clinical nutrition. Current Opinion in Clinical Nutrition and Metabolic Care 10: 12-19.
91. Etgen T, Sander D, Bickel H, Sander K, Forstl H, (2012) Vitamin D Deficiency, Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Dementia and Geriatric Cognitive Disorders 33: 297-305.
92. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, et al. (2012) Vitamin D, cognition, and dementia A systematic review and meta-analysis. Neurology 79: 1397-1405.
93. Liu LH, Zabaras D, Bennett LE, Aguas P, Woonton BW, (2009) Effects of UV-C, red light and sun light on the carotenoid content and physical qualities of tomatoes during post-harvest storage. Food Chemistry 115: 495-500.
94. AOAC (2006) Fat in milk. Modified Mojonnier ether extraction method.
95. Japelt RB, Silvestro D, Smedsgaard J, Jensen PE, Jakobsen J, (2011) LC-MS/MS with atmospheric pressure chemical ionisation to study the effect of UV treatment on the formation of vitamin D-3 and sterols in plants. Food Chemistry 129: 217-225.
96. Higashi T, Awada D, Shimada K, (2001) Simultaneous determination of 25-hydroxyvitamin D-2 and 25-hydroxyvitamin D-3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biological & Pharmaceutical Bulletin 24: 738-743.
97. Morris R, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 11: 47-60.
98. Morris RGM, (1990) Toward a representational hypothesis of the role of hippocampal synaptic plasticity in spatial and other forms of learning. Cold Spring Harbor Symposia on Quantitative Biology 55: 161-173.
99. Barnes CA, (1979) Memory defecits associated with senescence- neurophysiological and behavioural study in the rat. Journal of Comparative and Physiological Psychology 93: 74-104.
100. Lalonde R, (2002) The neurobiological basis of spontaneous alternation. Neuroscience & Biobehavioral Reviews 26: 91-104.
101. Hughes RN, (2004) The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neuroscience & Biobehavioral Reviews 28: 497-505.
102. Short JL, Ledent C, Drago J, Lawrence AJ, (2006) Receptor crosstalk: Characterization of mice deficient in dopamine D-1 and adenosine A(2A) receptors. Neuropsychopharmacology 31: 525-534.
103. McPherson CS, Mantamadiotis T, Tan SS, Lawrence AJ, (2010) Deletion of CREB1 from the Dorsal Telencephalon Reduces Motivational Properties of Cocaine. Cerebral Cortex 20: 941-952.
104. Tammer AH, Coia G, Cappai R, Fuller S, Masters CL, et al. (2002) Generation of a recombinant Fab antibody reactive with the Alzheimer's disease-related A beta peptide. Clinical and Experimental Immunology 129: 453-463.